Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Dose-finding Study of LIP-01 in Otherwise Healthy Individuals With Hypercholesterolemia

NCT00966225 is registered in ClinicalTrials.gov with Afexa Life Sciences Inc as lead sponsor.

NCT NCT00966225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00966225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Dose-finding Study of LIP-01 in Otherwise Healthy Individuals With Hypercholesterolemia
Lead sponsor
Afexa Life Sciences Inc
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2009
Completion date
January 31, 2012
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia